Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
Net Change in Cash
Fusion Antibodies PLC
Net Change in Cash Peer Comparison
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fusion Antibodies PLC
LSE:FAB
|
Net Change in Cash
-£719k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Net Change in Cash
-£136.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Net Change in Cash
£12.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Diaceutics PLC
LSE:DXRX
|
Net Change in Cash
£166k
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
Ergomed PLC
LSE:ERGO
|
Net Change in Cash
£14.1m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
hVIVO PLC
LSE:HVO
|
Net Change in Cash
£8.5m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Fusion Antibodies PLC's Net Change in Cash?
Net Change in Cash
-719k
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Net Change in Cash amounts to -719k GBP.
What is Fusion Antibodies PLC's Net Change in Cash growth rate?
Net Change in Cash CAGR 1Y
9%
Over the last year, the Net Change in Cash growth was 9%.